The Clinical Trial Innovation Summit Returns to Roche Headquarters in Basel on 26 June 2025!

PanAgora Pharma and Roche are collaborating once again to bring the 5th Annual Clinical Trial Innovation Summit back to Basel this 26 June! This year's conference agenda will explore how life sciences organizations are delivering more patient-centric clinical trials and how digital health technologies (DHTs) are being implemented to improve efficacy measurement, patient recruitment, safety, and drug delivery.

Core themes and topics for the 2025 agenda include:

 • Industry Trends and Innovations in Virtual, Hybrid and Decentralized Trials: AI, DHT, Decentralized trials, Evolving Role of CRO’s, Global Perspective
• Patient Perspective: Keys to Engagement, Involvement, and Applying Learnings at Scale
• Identifying Innovations & Technologies Accelerating Patient-Centric Trials
• Ideas into Action: Keys to Delivering Inclusive Human-Centered Clinical Trials

Join 30+ speakers and 250+ senior-level clinical research, operations, and trial design leaders on 26 June at Roche headquarters in Basel!
Location
Roche Building 1
Grenzacherstrasse 124
4070 Basel, Switzerland
Date & Time
26 June 2025
09:00-17:30 Local Time (GMT+2)
Apéro to Follow
HOST SPONSOR
AGENDA THEMES

1. Industry Trends and Latest Innovations: AI, DHTs, Decentralised Trials

2. Accelerating Patient-Centric Trials: Innovations & Technologies

3. Enhancing Diversity in Clinical Trials: Stakeholder Perspectives

4. Ideas into Action: Delivering Human-Centered Clinical Trials


Speaking Faculty & Advisors
Sam Hariry
NOVARTIS
Léa Proulx
ROCHE
Ernst Bos
ROCHE
Paul Cooper
ROCHE
Bola Grace
GSK
Scott Askin
NOVARTIS
Nadir Ammour
SANOFI
Isabela Niculae
UCB
Suki Balendra
IMPERIAL COLLEGE HEALTHCARE NHS TRUST
Meri Kay Scott
ELI LILLY AND COMPANY
Dan Karlin
MINDMED
Lauren Sunshine
BMS
Angela Bilkhu
ROCHE
Joachim Lövin
NOVO NORDISK
Matteo Lai
EMPATICA
Thierry Lave
ROCHE
Sebastian Heinzmann
ROCHE
Marco Rafael
ROCHE
Steve Bourke
PERSONALPULSE
Amri Johnson
INCLUSION WINS
Alison Holland
MEDABLE
Aude Clement
ROCHE
Bruno Jolain
ROCHE
Thierry Lave
ROCHE
Lorcan Walsh
NOVARTIS
Judit Magos
IDORSIA
Richard Bobek
MSD
Stephan Cichos
BAYER
CoNFERENCE SCHEDULE

26 June 2025
09:00
Opening Remarks from the Conference Chairs

Ernst Bos, Global Medical Director, Roche
Paul Cooper, Personalised Healthcare Strategy Leader, 
Roche



CONTENT BLOCK 1 
INDUSTRY TRENDS AND INNOVATIONS


09:05
FIRESIDE EXPERT KICK-OFF

Industry Trends: Innovations in Clinical Trial Design and Execution

“What does it take to make the EU clinical trial landscape more competitive?”

• EU Policy
• Innovations in Design (AI/ML, Knowledge Management)
• Innovations in Execution (DHTs, Decentralized Trials, and Site Experience)

Isabela Niculae, Head, Clinical Innovation and Digital Solutions, Global Clinical Operations, UCB
Joachim Lövin, Decentralised Clinical Trial (DCT) Specialist, Novo Nordisk
Lorcan Walsh, Head, Digital Endpoint Capability Centre, Development, Novartis

Moderated by: Marco Rafael, Regulatory Science Policy Leader, Roche


09:30
CASE STUDY

Optimizing Drug Development with Actionable Data Insights:
Secondary Use of Data: Multimodal Data Assets


• Roche's Approach and Leadership in Data Re-use - ROI and Responsibility to Patients
• Development of Datamarts to Generate Insights for Study and CDP Design

Marta Carrasco, Biomedical Data Insights Development Leader, Roche


09:50
CASE STUDY

Patient Recruitment Enabled through EHRs
 
Nadir Ammour, Global Lead, Clinical Innovation & External Partnerships, Sanofi


10:10
AI-Driven Clinical Trials: Accelerating Patient-Centric Breakthroughs in Research and Efficiency

Alison Holland, Chief Customer Officer, Medable


10:30
Networking Break
CONTENT BLOCK 2
Accelerating Patient-Centric Trials



11:00
CASE STUDY

Navigating Operational Challenges of Multimodal DHT Trials

Speaker TBA


11:20
CASE STUDY

Scaling Clinical Innovation - The Novartis Operating Model for Sustainable Success

This session will explore how Novartis’s Clin Ops Innovation team is transforming clinical operations. Discover how their comprehensive operating model scales innovation through a structured framework, ensuring alignment with operational needs and challenges. Learn how they measure success with clear criteria, match specific innovations to operational requirements, and consistently assess the innovation landscape to identify new opportunities. This session will provide valuable insights into Novartis’s systematic approach to driving sustainable, value-driven innovation in clinical trials.

Scott Askin, Portfolio Innovation Director, Global Clinical Operations, Novartis 


11:40
Bringing Clinical Trials Direct-to-Patient

Rachel Newsome, Product Manager, Cambridge Cognition


12:00
PANEL

Identifying Innovations & Technologies Accelerating Patient-Centric Trials

Lauren Sunshine, Director, Product Management, Digital Health, Bristol Myers Squibb
Bola Grace, Senior Director, Digital Health, Digital Biomarkers, 
GSK
Sam Hariry, Global Head, Clinical Innovation, Novartis Institutes for BioMedical Research (NIBR)
Suki Balendra, Director of Strategic Partnerships, Imperial College Healthcare, NHS Trust

Moderated by: Judit Magos, Clinical Operations Manager, Idorsia 


12:30
NETWORKING LUNCH
CONTENT BLOCK 3
Enhancing Diversity in Clinical Trials


13:30
PANEL

Patient Perspectives & Cultural Considerations in Clinical Trials

This panel will bring together a group of patients to explore how their perspectives on cultural considerations in clinical trials.

Moderated by: Steve Bourke, Founder, PersonalPulse


13:50
CASE STUDY

End to End Inclusive Research

What can early development bring to late stage development?

Thierry Lave, R&D Academy and Faculty Lead, Roche


14:10
CASE STUDY

IHI READI 

This session will explore the collaboration behind the IHI-funded project - IHI READI - aimed at fostering a more cohesive and integrated clinical studies ecosystem for underserved (US) and underrepresented (UR) communities.

Lea Proulx,
 Patient Voice Partner, Roche


14:30
CASE STUDY

Frailty Diversity in Oncology Trials

Sebastian Heinzmann, Global Medical Science Leader, Roche


14:50
NETWORKING BREAK


CONTENT BLOCK 4
IDEAS INTO ACTION

15:15
CASE STUDY

Technology Fit for Purpose:
Understanding of Potential Issues to Decrease Patient Burden On Your Study

Stephan Cichos, Strategic Project Leader, Clinical Data Strategy & Operations, Bayer


15:35
CASE STUDY

How MindMed is Deploying AI to do Analysis of Patient Interviews Around the Primary Endpoint of All Clinical Studies

Dan Karlin, Chief Medical Officer, MindMed


15:55
CASE STUDY

MSD’s In-House Site Selection Application – Data-Driven Performance Ranking for Optimized Clinical Trials

Richard Bobek, Associate Director, Clinical Data Science, MSD


16:15
Patient Perspective: First Hand Experience with DCTs

Patient Speaker TBA


16:30
CLOSING PANEL

DHTs in Clinical Trials: Reality Check and Key Takeaways from Patient and Site Interactions

Meri Kay Scott, Associate Vice President, Digital Health R&D, Eli Lilly & Company
Suki Balendra, Director of Strategic Partnerships, Imperial College Healthcare, NHS Trust
Matteo Lai, Chief Executive Officer,
 Empatica


16:55
Closing Reflection

Ernst Bos, Global Medical Director, Roche
Paul Cooper, Personalised Healthcare Strategy Leader, 
Roche


17:00
APÉRO & NETWORKING RECEPTION!


Sponsors & Exhibitors
HOST SPONSOR
GOLD SPONSOR
GOLD SPONSOR
GOLD SPONSOR
EXHIBITOR
EXHIBITOR
EXHIBITOR
SUPPORTING SPONSOR
SUPPORTING SPONSOR
Interested in Sponsorship or 
Exhibition Opportunities?
Conference Venue
Roche Tower (Building 1)
The Clinical Trials Innovation Summit (26 June) and the Digital Biomarkers Summit (25 June) will both be held in the Auditorium of Building 1 on the Roche campus in Basel.

Address:
Roche Tower (Building 1)
Grenzacherstrasse 124
4070 Basel, Switzerland


About: The office high-rise, Building 1, is a key pillar of Roche's site development strategy. With its straightforward yet unmistakable design, it blends in perfectly with the Roche grounds and the Basel cityscape. With 41 floors and workspace for around 2,000 employees, the office high-rise also shows a clear commitment to the Basel site.
Hotel Room Block
Hyperion Hotel Basel

(4 Star Hotel) Hyperion Hotel Basel in Basel, Switzerland
Location: Messepl. 12, 4058 Basel, Switzerland

In Basel's tallest habitable building, the HYPERION Hotel Basel is next to the Basel Messe trade fair center and just a short walk from the Old Town. It offers a sauna and a fitness center. Each of the 224 non-smoking guest rooms offers panoramic views of the city, free WiFi, air conditioning, refreshing bath products, a safe, hair dryer, and flat-screen TV with Sky channels.

PanAgora Pharma has a conference room block at the Hyperion Hotel Basel - just 1km from Roche Building 1. To book your room at the preferred room block rate, please use this link: CTIS Room Block at Hyperion Hotel Basel

***The Room Block closes on 13 May 2025, so we encourage all attendees staying in Basel to please make your reservation before then.

Processing Registration...